- Dec 29, 2017

Uncovering molecular targets for childhood cancer therapeutics

In the past two decades, despite extensive efforts to identify the genes associated with 11q aberrations in NB, definitive answers are still unclear. This distinct gap in the field has spurred a team of Tokyo Medical and Dental University (TMDU)-centered researchers to investigate the role of the gene ATM and DNA damage response (DDR)-associated molecules located in 11q. A report of the results was recently published.

Intensive Treatment May Pose Fertility Risks in Childhood Cancer Survivors

They survived childhood cancer. But the disease has taken a toll on their mental health.

How you can support a parent who has a child with cancer

Developing ‘kinder’ treatments for a devastating childhood cancer

Breakthrough as new drug promises to shield child cancer patients from hearing loss

Study finds higher breast cancer risk after certain forms of childhood cancer treatment

Aggressive Cancer Cells Transformed Into Healthy Cells in Breakthrough

Cardiac RT May Amplify Late Disease Risk in Pediatric Cancer Survivors

Are Cannabis-Based Medicines Safe for Children With Cancer?

Homoharringtonine May be ‘Better Alternative’ to Etoposide In Pediatric AML

Recent Posts

Uncovering molecular targets for childhood cancer therapeutics

Archive

Search By Tags